OPLEZEVE Trademark

Trademark Overview


On Tuesday, July 15, 2025, a trademark application was filed for OPLEZEVE with the United States Patent and Trademark Office. The USPTO has given the OPLEZEVE trademark a serial number of 99284520. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, December 23, 2025. This trademark is owned by Merck Sharp & Dohme B.V.. The OPLEZEVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations
oplezeve

General Information


Serial Number99284520
Word MarkOPLEZEVE
Filing DateTuesday, July 15, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, December 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 23, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 15, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMerck Sharp & Dohme B.V.
Party Type20 - Owner at Publication
Legal Entity Type26 - NOT AVAILABLE
AddressHAARLEM 2031BN
NL

Party NameMerck Sharp & Dohme B.V.
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressHAARLEM 2031BN
NL

Trademark Events


Event DateEvent Description
Tuesday, July 15, 2025NEW APPLICATION ENTERED
Tuesday, July 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 15, 2025APPLICATION FILING RECEIPT MAILED
Friday, September 19, 2025ASSIGNED TO EXAMINER
Saturday, September 20, 2025SUSPENSION LETTER WRITTEN
Saturday, September 20, 2025LETTER OF SUSPENSION E-MAILED
Saturday, September 20, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 26, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, November 30, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 17, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 23, 2025PUBLISHED FOR OPPOSITION
Tuesday, December 23, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED